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Abstract—Current mechanical conditioning approaches for heart
valve tissue engineering concentrate on mimicking the opening
and closing behavior of the leaflets, either or not in combina-
tion with tissue straining. This study describes a novel approach
by mimicking only the diastolic phase of the cardiac cycle, re-
sulting in tissue straining. A novel, yet simplified, bioreactor
system was developed for this purpose by applying a dynamic
pressure difference over a closed tissue engineered valve, thereby
inducing dynamic strains within the leaflets. Besides the use of
dynamic strains, the developing leaflet tissues were exposed to
prestrain induced by the use of a stented geometry. To demonstrate
the feasibility of this strain-based conditioning approach, human
heart valve leaflets were engineered and their mechanial behavior
evaluated. The actual dynamic strain magnitude in the leaflets
over time was estimated using numerical analyses. Preliminary
results showed superior tissue formation and non-linear tissue-
like mechanical properties in the strained valves when compared
to non-loaded tissue strips. In conclusion, the strain-based condi-
tioning approach, using both prestrain and dynamic strains, offers
new possibilities for bioreactor design and optimization of tissue
properties towards a tissue-engineered aortic human heart valve
replacement.
Keywords—Heart valve prostheses, Bioreactor, Mechanical
conditioning, Straining, Modeling.
INTRODUCTION
In cardiovascular tissue engineering, stimulation of tis-
sue formation by mechanical conditioning has proven to be
a useful tool for development of functional cardiovascular
structures enabling growth, repair, and remodeling. The
most common way of conditioning a developing tissue is
by mimicking its physiological environment in vivo. Var-
ious bioreactor systems have been developed in the past
years to apply specific conditioning protocols to growing
cardiovascular structures.
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Bioreactors developed for tissue engineering of heart
valves all mimic the opening- and closing behavior of the
heart valves in vivo.8,9 By using pulsatile medium flow
through the developing valve, the systolic phase of the car-
diac cycle is represented. The diastolic phase is represented
when the valve leaflets are closed, due to minimal flow,
and medium is resting onto the valve leaflets, inducing
a pressure difference. Similar to heart valves, developing
blood vessels are also conditioned by mimicking the full
physiological environment.19,28,34 Pulsatile flow through
the vessel lumen represents the blood stream and due to
the pulsatile character of the flow, mimicking the cardiac
output at every heartbeat, the blood vessel wall is strained.
More complex systems, ensuring exact physiological con-
ditions, have been developed for both blood vessels14,15,30
and heart valves5,7,23 and can be used for testing purposes
as well.
Despite these efforts, the question still remains whether
the developing tissue should indeed be exposed to all me-
chanical cues present in its physiological environment, or
whether it is more beneficial to mimic its environment only
partly. Tissue-engineered blood vessels, for example, were
shown to grow and develop very well in bioreactors that
only used dynamic wall straining, without the use of pul-
satile flow.20,21,27 Culturing in an initial low shear stress
environment combined with exposure of the developing
tissue to physical stimuli has been suggested by Barron
et al.1 as well to be advantageous for initial tissue devel-
opment. In this study, the hypothesis of mimicking only
the phase of the cardiac cycle in which the heart valve is
most prone to dynamic straining, being beneficial for tissue
growth and development, is tested. A prerequisite for the
application of strains in this approach is to ensure a non-
porous tissue structure. For this purpose, fibrin was used as
a cell carrier.17 In the field of heart valve tissue engineering,
this strain-based conditioning approach, without the use of
pulsatile flow, has not been described and tested before.
In order to mimic solely the phase of the cardiac cy-
cle where the tissue is being strained, a new bioreactor
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system is developed, the Diastolic Pulse Duplicator (DPD).
In this system, dynamic strains are induced in the heart
valve leaflets by applying a dynamic pressure difference
over the closed valve leaflets. Requirements for such a
bioreactor system are: (1) simplicity in its use, (2) sized
small to save on culture medium and incubator space,
(3) usage of biocompatible materials, (4) maintenance of
sterility over prolonged periods of time, and (5) the ability
to monitor and control the applied transvalvular pressure.
Compaction-induced prestrain develops in the leaflets as
tissue compaction, common in growing and healing tissues,
is constrained by the use of a rigid stent. Theoretically, the
amount of dynamic strains can be monitored using markers
on the leaflets. As this is a time-consuming and in practice
rather difficult method, we have chosen to estimate the
range of dynamic strains in the leaflets by finite element
analyses.
The cells in the tissue-engineered structures are respon-
sible for the formation of the extracellular matrix and via
mechanical conditioning they can be stimulated to pro-
duce larger amounts of extracellular matrix. Apart from
the nature and magnitude of the mechanical cues, the cel-
lular (pheno)type as well as the culture conditions (either
2D or in a 3D environment) affect the cellular responses
to mechanical loading.2,3,6,10–13,22,32,33. In this study, hu-
man saphenous vein cells were chosen as a cell source
for tissue engineering of human heart valve leaflets. Not
only do they represent an easily accessible cell source,
they were also shown to be more sensitive to mechan-
ical cues compared to human arterial derived cells.3,25
Furthermore, increased extracellular matrix formation
has been demonstrated in engineered heart valve leaflet
tissue-equivalents cultured with these cells using dynamic
strains.16
The feasibility of the use of the DPD for human
heart valve leaflet tissue engineering is demonstrated and
preliminary results are presented, based on non-woven
polyglycolic acid (PGA) meshes coated with poly-4-
hydroxybutyrate (P4HB). Tissue formation was analyzed
qualitatively and mechanical properties quantitatively of
engineered leaflets exposed to prestrain and additional dy-
namic strains and prestrain only and compared to unloaded
tissue strips, serving as control.
MATERIALS AND METHODS
Preparation of the Leaflet Tissues
The Heart Valve Scaffold
Trileaflet heart valve scaffolds were fabricated on a
Fastacryl stent. The two components, Fastacryl pow-
der and fluid (PMMA and MMMA, Vertex-dental, the
Netherlands) were mixed, poured into a mold, and allowed
to polymerize for 30 min. After complete polymerization,
the stent was released from the mold. Anatomically shaped
leaflets, including coaptation areas (Fig. 1(a)), were cut out
of non-woven polyglycolic acid meshes (PGA; thickness
1.0 mm; specific gravity 69 mg/cm3; Cellon, Luxembourg).
The resulting stented valve leaflet geometry can be de-
scribed using the parameters defined by Thubrikar:31 the
angle of open leaflet (β) = 0, radius of the commis-
sures (Rc) = radius of the base (Rb) = 11.5 mm, and
valve height (H) minus height of the commissures (Hs) =
13 mm. The leaflets were coated with a thin layer of poly-
4-hydroxybutyrate (P4HB; MW 1 × 106; TEPHA Inc.,
Cambridge, USA) as described before.8 Before evapora-
tion of the solvent, the leaflets were positioned onto a teflon
mold in the shape of a trileaflet heart valve. The fastacryl
stent was placed on top. By action of the solvent, dissolving
the surface layer of the stent, the leaflets were fixed to the
stent. After evaporation of the solvent, the valve scaffold
including the stent was removed from the mold (Fig. 1(b)
and (c)). The valve scaffolds were sterilized using ethylene
oxide.
FIGURE 1. Two-dimensional valve leaflet geometry (a) and photographs of the stented valve scaffold, bottomview (b) and topview (c).
The scaffold is fabricated from a non-woven PGA mesh, coated with P4HB and includes a fastacryl stent fixed to the leaflets. The
initial circumferential size of the leaflets is 23 mm. The leaflets contain coaptation areas to ensure closure of the valve.
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Seeding Procedure
Cells harvested from the human vena saphena magna and
expanded using regular cell culture methods were used.25
The medium to culture these cells consisted of DMEM
Advanced (Gibco, USA), supplemented with 10% Fetal
Bovine Serum (FBS; PAN Biotech, Germany), 1% Glu-
taMax (Gibco, USA), and 0.1% gentamycin (PAN Biotech,
Germany). The medium used for seeding and subsequent
tissue culture contained 0.3% gentamycin and additional
L-ascorbic acid 2-phosphate (0.25 mg/ml; Sigma, USA)
to promote extracellular matrix production. The scaffolds
were placed in medium overnight before seeding to facili-
tate cell attachment by deposition of proteins. The seeding
was performed per leaflet using fibrin as a cell carrier.17
Briefly, the cells were suspended in a sterile thrombin so-
lution (10 IU/ml medium; Sigma, USA) in a volume that
equals half the void volume of the scaffold (0.5 × length ×
width × thickness). The cells in thrombin were mixed with
an equal amount of sterile fibrinogen solution (10 mg ac-
tual protein/ml medium; Sigma, USA) and dripped onto the
scaffold. The fibrin solution was taken up by the scaffold
and remained inside due to polymerization of the fibrin gel.
The leaflets were seeded with a density of 4–5 million cells
(passage 6–7) per cm2 of scaffold. The seeded valve scaf-
folds were allowed to polymerize for 20 min in an incubator
(37◦C and 5% CO2) before placement into the DPD.
The Diastolic Pulse Duplicator (DPD)
Description of the DPD
Each DPD consists of two components as shown in
Fig. 2(a): a bioreactor (height = 9 cm, diameter = 6 cm),
in which the valve is cultured, and a medium container
of similar dimensions, both fabricated from polycarbonate
(KUBRA Kunststoffen, The Netherlands). The bioreactor
itself consists of two parts, the upper part containing a
glass window (Melles Griot BV, The Netherlands) for visu-
alization of the valve, and a lower part, which are screwed
together. Silicone rings (van der Heijden, The Netherlands)
are used to seal all components. The bioreactor and the
medium container are connected via two parallel silicone
tubing series (Rubber, The Netherlands). Polypropylene
connector parts (Neolab, Milispec Int., The Netherlands)
are used to secure the tubing. Both tubing series run through
a roller pump (Masterflex, Cole-Parmer, USA). Part of
the upper tubing series consists of a thicker silicone tube
placed in a polycarbonate cylinder, with a connection to
tubing suitable to withstand air under pressure (Festo, The
Netherlands). This compressed-air tubing is connected to a
compressed-air tap (7 bar). The air pressure is reduced to
2 bar and runs through a proportional magnet valve (Festo,
The Netherlands) into the polycarbonate cylinder. The com-
plete DPD is sterilized by ethylene oxide and is placed in-
side an incubator, together with the roller pump. Up to six
FIGURE 2. Schematic drawing of one DPD and its function
(a) and a photograph of six DPD systems in use simultane-
ously (b). One DPD consists of a bioreactor (A), in which the
valve is cultured, and a medium container (B). They are con-
nected to each other via two parallel tubing series (C), which
run through a roller pump (D). Part of the upper tubing consists
of a thicker tube placed in a polycarbonate cylinder (E). Com-
pressed air can be released into this cylinder, via a magnet
valve (F), to compress and decompress the tubing, resulting
in a pressure difference over the leaflets. A syringe (G), placed
on the bioreactor, serves as a compliance chamber. The pres-
sures upstream and downstream of the leaflets is monitored
using pressure sensors (H).
DPDs are placed onto one shelf of a normal sized incubator
as shown in Fig. 2(b).
Functioning of the DPD
About 75 ml of medium is circulating from the medium
container, through the bioreactor, and back into the medium
container, via the roller pump at very low speed (4 ml/min)
to supply fresh nutrients to and to remove waste products
from the developing valve tissue. A sterile filter (0.2 µm,
Schleicher & Schuell Bioscience, Germany) is placed in
the lid of the medium container to oxygenate the circu-
lating medium. About 25 ml of medium is present in the
bioreactor and the tubing series, and the remaining 50 ml
is present in the medium container and can be changed
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easily. To apply a dynamic pressure difference over the
leaflets, the silicone tube in the polycarbonate cylinder
is compressed and decompressed by the air coming from
the proportional magnet valve. The transvalvular pressure
generated over the valve leaflets is controlled via a pro-
grammable multi-IO-card using Lab View software (Na-
tional Instruments, USA). The shape and frequency of the
pressure wave is programmed for an optimal transvalvu-
lar pressure. A syringe, connected to the lower part of
the bioreactor, filled with 10 ml of medium and 40 ml of
air, serves as compliance chamber. Pressure sensors (BD,
Belgium), connected to both the lower and upper part of
the bioreactor, are used to measure the pressure upstream
(at the ventricular side) and downstream (at the arterial
side) of the leaflets. Using the same multi-IO-card and soft-
ware, the dynamic pressure difference is monitored and
logged.
Sterility and Biocompatibility
To prove maintained sterility over several weeks, the
DPD was sterilized by ethylene oxide and filled with 75 ml
of culture medium without the addition of gentamycin. The
system was fully functional for a period of 3 weeks. During
the testing period, a culture flask filled with culture medium,
without gentamycin, served as control. The medium in the
medium container was replaced every 3–4 days as well as
two thirds of the medium in the culture flask. The medium
was checked microscopically for contamination and was
stored at −20◦C until further use.
In order to ensure that the materials used in the DPD
are suitable for cultivation of heart valves and that no toxic
components are being released, a biocompatibility test was
performed using the medium that was stored during the
sterility test. Human saphenous vein cells were seeded into
24 wells plates (30.000 cells/well) and left overnight to
attach and spread in an incubator in normal cell culture
medium. The next day, the normal cell culture medium
was replaced by the medium of the sterility test that had
circulated through the DPD and the control medium (5
wells per test group). The medium stored after the first four
medium changes, as well as the control medium from the
culture flask, was used. The cells were allowed to grow
for three subsequent days, after which the metabolic ac-
tivity of the cells, as a measure for viability, was deter-
mined using an MTT test.18 Briefly, MTT (Sigma, USA)
in solution (5 mg/ml in PBS) was diluted in medium and
added to the cells. After one hour of incubation at 37◦C and
5% CO2, metabolic active cells had converted the MTT salt
into purple crystals located inside the cells. Isopropanol
(VWR International, USA), containing 10% formic acid
(Sigma, USA) was added to the cells to release and dissolve
the purple crystals and the optical density of the solution
was determined. The results are expressed as percentages
with respect to the control, which was set at 100%.
Tissue Culture and Mechanical Conditioning
To demonstrate the feasibility of the strain-based condi-
tioning approach, a preliminary experiment was performed.
Three groups of valve leaflet tissues were engineered (n = 3
per group, Table 1) to compare tissue formation and me-
chanical properties. The first group comprises rectangular
shaped tissue strips. They were cultured statically in a cell
culture flask for up to 4 weeks and could compact freely,
serving as non-loaded controls. The second and third group
consisted of valve leaflets, all cultured in the DPD. Di-
rectly after placement in the DPD, all leaflets were exposed
to medium circulation at low speed (4 ml/min) to supply
fresh nutrients to the developing tissue. Valve leaflets were
cultured up to 4 weeks, exposed to continuous medium
circulation and prestrain due to compaction constrained by
the stent (group 2). Additional valve leaflets were exposed
to dynamic strains at 1 Hz in addition to the prestrain and
continuous medium circulation (group 3). The pressures
upstream and downstream of the valves, as well as the
dynamic transvalvular pressure, were recorded every three
hours. The valve leaflets of group 3 were cultured up to 2,
3, and 4 weeks. The medium in the medium container, as
well as two thirds of the medium in the culture flask for
group 1, was replaced every 3–4 days.
Evaluation of Tissue Formation
Histology
Tissue formation in all groups was analyzed by his-
tology after 4 weeks. Representative pieces were fixed in
phosphate-buffered formalin (Fluka, USA) and embedded
TABLE 1. Overview of the experimental groups: (1) non-loaded tissue strips, (2) leaflets exposed to prestrain in the DPD, and
(3) leaflets exposed to prestrain and additional dynamic strains in the DPD.
Group no Geometry Culture conditions Mechanical conditioning Culture time Number of leaflets (n)
1 Strips Static in flask None 4 weeks 3
2 Leaflets Medium circulation in DPD Prestrain 4 weeks 3
3 Leaflets Medium circulation and Prestrain and dynamic strain 2, 3, and 4 weeks 3 per time point
dynamic strains in DPD
Note. An n of 1 comprises a single engineered leaflet tissue.
1782 MOL et al.
in paraffin. Sections were cut at 5 µm thickness and stud-
ied by Haematoxylin and Eosin (H&E) staining for gen-
eral tissue morphology and Trichrome Masson staining for
collagen formation, as collagen is the main load-bearing
component of the extracellular matrix.
Mechanical Tests
The mechanical properties of circumferential strips of
the engineered leaflet tissues of the three groups after
4 weeks of culturing were determined by uniaxial tensile
tests. As thickness measurements of the fresh strips were
practically difficult, the thickness was determined from rep-
resentative histology sections. A tissue volume shrinkage
correction factor of 1.15 (1.046 linear shrinkage) was used
to correct for the supposed loss of tissue volume due to tis-
sue processing.24 Stress-strain curves were obtained using
an uniaxial tensile tester (Instron, Belgium, model 4411,
equipped with a load cell of 10 N) with a constant strain
rate of 1.7% per second. From the stress-strain curves, the
ultimate tensile strength (UTS) was determined, as well as
the strain at break. The modulus was calculated, defined as
the slope of the linear portion of the curve. To get insight
into the evolution of mechanical properties in time, the
mechanical properties of circumferential strips of dynami-
cally strained leaflets after 2 and 3 weeks of culturing were
additionally determined.
Statistics
Results of the mechanical tests are expressed as mean ±
standard error of the mean. One-way ANOVA analyses
were used to determine significant differences between
the tested groups, followed by Tukey HSD post-hoc tests
between groups (STATGRAPHICS Plus 5.1, Statistical
Graphics Corp., USA) in case of a significant result. Dif-
ferences were considered significant at a p-value <0.05.
Estimation of Strains in the Leaflets
Prestrain
To estimate the amount of prestrain in the leaflets, due
to compaction constrained by the stent, the difference in
size of the leaflets in the stent after culturing and after
release from the stent was determined. The leaflets, hav-
ing an initially bulged shape in the stent, did straighten
during culturing due to free compaction of the neo-tissue.
The initial circumferential size of the leaflets was 23 mm
(Fig. 1(a)). This circumferential size was reduced to 20 mm
by straightening of the leaflets in the stent during cultur-
ing (Fig. 3(a)), indicating that the leaflets could compact
freely up to 13% during culturing. The circumferential size
of each leaflet was measured after release from the stent
(Fig. 3(b)) of the valves exposed to prestrain and medium
circulation after 4 weeks. This measured size was divided
FIGURE 3. The circumferential size of the fully flattened
leaflets in the stent after culturing (a) was 20 mm. After release
of the leaflets from the stent (b), the circumferential size was
measured and the difference in size was used to calculate the
amount of prestrain in the leaflets during culturing.
by the maximally straightened size of 20 mm to calculate
the amount of prestrain in the leaflets. This value was subse-
quently extracted from 1 and multiplied by 100% to obtain
the amount expressed in a percentage of prestrain.
Dynamic Strains
Finite element analyses were used to estimate the amount
and distribution of the dynamic strains in the leaflets result-
ing from the applied dynamic transvalvular pressure. The
finite element mesh of the stented valve geometry is shown
in Fig. 4. The configuration shown in this figure was as-
sumed to be stress-free and because of symmetry only 1/2
of a valve leaflet was used in the finite element analyses.
At the symmetry edge, nodal displacements in the normal
direction were suppressed, whereas at the fixed edge all
nodal displacements were set to zero. At the free edge, a
contact surface was defined to model coaptation of adjacent
leaflets. The transvalvular pressure ptv was subsequently
FIGURE 4. Finite element mesh of the stented valve geometry.
Because of symmetry only 1/2 of a leaflet is used in the fi-
nite element analyses. This part of the geometry is discretized
using 224 hexahedral elements.
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applied to the downstream surface of the leaflets. In
this study, the finite element package SEPRAN was
used.26
The valve tissues were modeled as an incompressible
generalized Neo-Hookean material:
σ = −p I + G(B − I) (1)
with σ the Cauchy stress, p the hydrostatic pressure,
I the unity tensor, and G the shear modulus of the ma-
terial. The left Cauchy-Green deformation tensor was de-
fined as B = F · FT with F the deformation gradient
tensor. To describe the (potential) non-linear behavior of
the leaflet tissues, the following expression for G was
used:
G = G0
(
I1(B)
3
)n
(2)
with G0 and n material parameters and I1(B) = trace(B)
the first invariant of B. The parameter n is used to control
the degree of non-linearity of the constitutive equation:
n > 0 indicates stiffening of the material with increasing
stretches, whereas n < 0 indicates softening. Note that the
classical Neo-Hookean model is obtained for n = 0, with
G = G0. The material parameters were obtained by fitting
the constitutive law (Eq. (1)) to the mean results before fail-
ure of the uniaxial tensile tests of the leaflet tissues exposed
to dynamic strains after 2, 3, and 4 weeks of culturing.
RESULTS
The Diastolic Pulse Duplicator
The medium, without addition of antibiotics, which had
circulated in the DPD did not show any macroscopic or
microscopic signs of contamination for the complete test
period. The system was easy to handle and the risk of
contamination during medium replacement was minimal.
The results of the biocompatibility test, performed for the
first four medium changes during the sterility test, are
shown in Fig. 5. The metabolic activity of the cells cul-
tured with the four tested media were all within 80–100%
when compared to the controls, indicating the DPD to be
biocompatible and suitable for cultivation of human heart
valves.
Dynamic Straining Protocol
A representative transvalvular pressure curve, mea-
sured during culturing, is shown in Fig. 6. The permanent
transvalvular pressure, present over the valve leaflets, is
referred to as the DC offset, which is the average value of
the difference in pressure upstream and downstream of the
leaflets. The cyclic transvalvular pressure is defined as the
peak-to-peak transvalvular pressure value. The maximum
transvalvular pressure value, including the DC offset and
FIGURE 5. Metabolic activity of cells cultured with the first
four changes of the medium that had circulated in the DPD
during the sterility test. The tested medium (dark gray bars)
was compared to control medium (light gray bars), which was
set at 100%. The metabolic activity was in all cases 80–100%
compared to the controls and, therefore, the DPD can be con-
sidered as being biocompatible. The error bars represent the
standard error of the mean.
the cyclic transvalvular pressure, is referred to as the applied
dynamic transvalvular pressure.
The dynamic transvalvular pressure was averaged for
each day, resulting in dynamic transvalvular pressures
increasing gradually from 0 to about 80 mm Hg within the
first 2 weeks of culturing (10 mm Hg at day 7, 30 mm Hg
at day 9, 70 mm Hg at day 12, and 80 mm Hg at day 14).
During the last 2 weeks of culturing, the pressures were
lowered due to the expected loss of support function of the
scaffold, and kept constant at about 37 mm Hg.
Evaluation of Tissue Formation
Histology
Sections stained with H&E and Trichrome Masson
(Fig. 7) showed superior tissue formation in the leaflets
FIGURE 6. A representative transvalvular pressure curve mea-
sured during culturing of the valve leaflets. The definitions of
DC offset, cyclic transvalvular pressure difference, and dy-
namic transvalvular pressure difference are represented.
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FIGURE 7. Representative sections of the valve leaflet tis-
sues after 4 weeks of culturing stained with H&E (a,c,e) and
Trichrome Masson (b,d,f). The bars in the images represent
scales of 175 µm. The dynamically strained leaflets (a,b) and
the leaflets exposed to prestrain only (c,d) showed superior
tissue development when compared to the non-loaded valve
leaflet tissue-equivalents (e,f). The dynamically strained leaflet
tissue seemed more homogeneous and denser as compared to
the leaflets exposed to prestrain only. Collagen, stained blue,
could be identified in the leaflets (b,d).
(Fig. 7(a)–(d)) when compared to the non-loaded rectan-
gular leaflet tissue-equivalents (Fig. 7(e) and (f)). The tis-
sue of the leaflets cultured with additional dynamic strains
(Fig. 7(a) and (b)) appear to be more homogeneous and
denser when compared to the leaflets exposed to prestrain
only (Fig. 7(c) and (d)). Collagen could be identified in
the leaflets, either cultured using prestrain or additional
dynamic strains, after 4 weeks of culturing as shown in
Fig. 7(d) and (b).
Mechanical Tests
The obtained stress-strain curves were averaged until
failure per group and timepoint (Fig. 8). The values for
UTS, modulus, and strain at break are summarized in
Table 2. After 4 weeks, both leaflet types, either cultured
using prestrain alone or using additional dynamic strains,
were significantly stronger (0.25 ± 0.02 MPa and 0.22 ±
0.04 MPa, respectively) and stiffer (1.03 ± 0.03 MPa and
0.78 ± 0.20 MPa, respectively) when compared to the non-
loaded tissue strips (UTS: 0.07 ± 0.03 MPa, modulus:
FIGURE 8. Stress-strain curves averaged before failure per
group and timepoint, showing the mechanical behavior of non-
loaded tissue strips, leaflets exposed to prestrain, and leaflets
exposed to prestrain and additional dynamic strains after 4
weeks (a) and the evolution of mechanical properties over
time for dynamically strained leaflets (b). The non-loaded tis-
sue strips showed linear mechanical behavior, while the leaflet
tissues showed tissue-like non-linear behavior after 4 weeks
of culturing (a). Dynamic straining of the leaflet tissues during
culturing resulted in more non-linear tissue-like mechanical
behavior with time (b).
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TABLE 2. Summary of the results of the uniaxial tensile tests per group and per timepoint. The values are
represented as average value ± standard error of the mean.
Group Timepoint (weeks) UTS (MPa) Modulus (MPa) Strain at break (%)
Prestrain and dynamic strains 2 0.11 ± 0.02 0.66 ± 0.08 19 ± 2
Prestrain and dynamic strains 3 0.12 ± 0.03 0.53 ± 0.14 42 ± 3#
Prestrain and dynamic strains 4 0.22 ± 0.04∗ 0.78 ± 0.20∗ 44 ± 1#
Prestrain 4 0.25 ± 0.02∗ 1.03 ± 0.03∗ 41 ± 4
Non-loaded strips 4 0.07 ± 0.03 0.18 ± 0.07 46 ±11
Note. Shown are the ultimate tensile strength (UTS), the modulus, and the strain at break. Significant differences
between the groups after 4 weeks of culturing are indicated (∗, p < 0.05) and shows the strips to be weaker and
less stiff when compared to both types of leaflets. Significant differences between the timepoints are indicated (#,
p < 0.05) and shows an increase in strain at break after 3 and 4 weeks of culturing.
0.18 ± 0.07 MPa). No differences were found between
leaflets cultured using prestrain and using additional dy-
namic strains. The non-loaded tissue strips showed lin-
ear mechanical behavior while the leaflets exposed to
compaction-induced prestrain, either with or without addi-
tional dynamic strains, showed more tissue-like non-linear
behavior (Fig. 8(a)).
With respect to the evolution of the mechanical proper-
ties over time of the dynamically strained leaflets, no sig-
nificant increases in UTS (0.11 ± 0.02 MPa after 2 weeks,
0.12 ± 0.03 MPa after 3 weeks, and 0.22 ± 0.04 MPa after
4 weeks) and modulus (0.66 ± 0.08 MPa after 2 weeks,
0.53 ± 0.14 MPa after 3 weeks, and 0.78 ± 0.20 MPa after
4 weeks) were identified. Strain at break increased after
3 and 4 weeks (19 ± 2% after 2 weeks, 42 ± 3% after
3 weeks, and 44 ± 1% after 4 weeks). It was evident that af-
ter 2 weeks of culturing the mechanical behavior was linear,
representing scaffold-like behavior. After 3 and 4 weeks,
the tissue showed more non-linear mechanical behavior,
representative for tissue contribution (Fig. 8(b)).
Estimation of Strains in the Leaflets
Prestrain
The leaflets were fully straightened in the stent
(Fig. 3(a)) and (partly) grown together. After releasing the
leaflets from one another, the leaflets retracted some, caused
by the prestrain in the leaflets, resulting in the loss of coap-
tation. The amount of prestrain in the leaflets of the valves
exposed to prestrain only after 4 weeks of culturing, assum-
ing maximal straightening of the leaflets, was 3.7 ± 0.8%
(mean value ± standard error of the mean).
Dynamic Strains
The constitutive law (Eq. (1)) fitted the results of the
uniaxial tensile tests quite reasonable. Table 3 summarizes
the input parameters for the finite element model, the mean
absolute error of the fits, and the estimated mean dynamic
strains after 2, 3, and 4 weeks of culturing, based on a
transvalvular pressure difference of 37 mm Hg. The mean
dynamic strains in the leaflets increased from 8 ± 4% after
2 weeks to 20 ± 7% after 4 weeks of culturing within one
leaflet. The dynamic strain distribution in the leaflets after
4 weeks of culturing is shown in Fig. 9, with in Fig. 9(a) and
(b) the strain distribution within one leaflet at the upstream
and downstream surface, respectively. Fig. 9(c) shows the
estimated range of overall dynamic strains within a leaflet
by means of a histogram.
DISCUSSION
Mechanical stimulation of tissue formation in a bioreac-
tor system is a well-known technique in tissue engineering
TABLE 3. Summary of the input parameters for the finite element analyses of the
dynamically strained leaflets after 2, 3, and 4 weeks of culturing.
Culture time Thickness Go Mean absolute Mean dynamic
(weeks) (mm) (kPa) n (−) error of fit (kPa) strain (%)
2 0.80 188 0.0 0.95 8 ± 4
3 0.59 51 8.6 3.93 24 ± 8
4 0.63 59 9.2 4.61 20 ± 7
Note. The parameter n was set to zero for the leaflets after 2 weeks of culturing, due
to the observed linear behavior. Furthermore, the mean absolute errors of the fits of
the constitutive law (Eq. (1)) to the results of the uniaxial tensile tests and the resulting
estimated mean dynamic strains are represented as mean value ± SD within one
leaflet.
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of cardiovascular structures to improve tissue formation
and organization. In this study, a novel bioreactor for tissue
engineering of human heart valve leaflets is developed and
preliminary results are presented to demonstrate its fea-
sibility. Instead of mimicking the full cardiac cycle, only
the phase in which the leaflets are most prone to dynamic
strain (diastole) is mimicked in this bioreactor, the Diastolic
Pulse Duplicator (DPD, Fig. 2). In the DPD, stented valve
leaflets are exposed to continuous medium circulation at
low speed (4 ml/min) to provide fresh nutrients to the tissue
and to remove waste products. The leaflets are exposed to
prestrain, induced by tissue compaction constrained by the
stent. Dynamic strains are additionally applied in the DPD
using a dynamic pressure difference over the leaflets. The
DPD is very easy to handle, sized small with a total medium
volume of only 75 ml per valve, proven to be biocompatible
(Fig. 5), and sterility could be maintained over prolonged
periods of time.
To show the feasibility of the use of the DPD and the
strain-based conditioning approach, three groups of leaflet
tissues were engineered (Table 1), based on human saphe-
nous vein cells, seeded using fibrin as a cell carrier onto
PGA/P4HB scaffolds (Fig. 1). Non-loaded tissue strips
showed lower mechanical properties and less tissue for-
mation after 4 weeks of culturing when compared to the
leaflets, which were exposed to prestrain only or to pre-
strain and additional dynamic strains (Table 2, Fig. 7). The
mechanical behavior of both leaflet types was clearly non-
linear after 4 weeks of culturing, while the tissue strips
showed linear behavior (Fig. 8(a)). The tissue of the leaflets
exposed to dynamic strains appeared to be more homoge-
neous and denser packed as compared to leaflets exposed
to prestrain only, however, this concerned only qualitative
observation by histology. The mechanical properties were
not significantly different for the two groups. Over time,
the leaflets exposed to dynamic strains showed more non-
linear tissue-like behavior (Fig. 8(b)), indicating increasing
amounts of tissue and collagen. The mechanical properties
of the tissues engineered in this study approached those of
native human aortic heart valve leaflets in radial direction.
The circumferential mechanical properties of native leaflets
are about 10 times higher.29 The continuous medium circu-
lation in the DPD most likely contributes to the improved
tissue formation in the leaflets. This contribution will be
elucidated in future studies as well as possibilities to mon-
itor tissue development during culturing by the identifi-
cation of biochemical markers in the circulating medium.
Furthermore, the application of larger flows in the DPD,
possibly necessitated later in the process after endothelial
cell seeding, has to be studied.
Due to compaction (flattening of the leaflets in the stent)
and prestrain in the leaflets, the leaflets lost coaptation af-
ter releasing them from one another, as they were (partly)
grown together. This emphasizes the importance of the ini-
tial geometry, which should be optimized in future studies
FIGURE 9. The dynamic strain distribution after 4 weeks of
culturing at the upstream (a) and downstream (b) surfaces
of the leaflets at an applied dynamic transvalvular pressure
difference of 37 mm Hg. The grayscale represents the amount
of dynamic strains in %. The relative amount of the overall
dynamic strains found in the leaflet and the mean value are
shown in the histogram (c).
to retain sufficient coaptation areas after culturing. The pre-
strain is estimated to be in the range of 3–5% and might
already be sufficient for optimized tissue formation and
mechanical properties. Although no significant differences
were found in mechanical properties when using additional
dynamic strains, we believe that dynamic straining might
further enhance tissue organization, based on the qualitative
observations by histology. Enhanced tissue organization
will represent itself in anisotropic mechanical properties
and elucidating these properties should be the focus of fu-
ture, more extensive, studies. Dynamic straining will be of
even larger importance in stentless valves as the prestrain
in those valves will be much less when dealing with a more
pliable aortic wall. The stent used in this study was solely
for experimental use and should be replaced by a tissue-
engineered wall for use in animal studies.
To get insight into the amount of dynamic strains applied
to the leaflets, the dynamic strain distribution was estimated
using numerical analyses. The mean dynamic strain within
the valve leaflets cultured in this study, as an example for fu-
ture use, were estimated to vary from 8% at 2 weeks to 20%
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at 4 weeks of culturing (Fig. 9 and Table 3). The estimated
dynamic strains tended to increase between week 2 and 3,
while the applied dynamic transvalvular pressures was de-
creased, indicating loss of scaffold support. The amount
of applied dynamic strains in this study might have been
too large for optimized tissue formation, but application
of large dynamic strains in the DPD was shown feasible.
As currently the strains in the leaflets are determined af-
terwards, a future research focus for optimization of the
Diastolic Pulse Duplicator is the development of a non-
invasive method to determine tissue strains directly during
culturing and to integrate this feature in a feedback loop to
control the magnitude of the strains.
In the numerical analysis, an initial stress-free configura-
tion of the leaflets is assumed, which is not completely true
as the valve leaflets show compaction during culturing. In
future studies, compaction behavior has to be incorporated
into the model. The material properties of the leaflets are
assumed to be homogeneous and isotropic, which might not
be the case after a certain culture period due to the influence
of prestrain in mainly the circumferential direction and the
local dynamic strain distribution in the leaflets. In case of
anisotropic properties, to be elucidated in future studies,
an extended model should be used for the finite element
analyses as described by Driessen et al.4.
In conclusion, the strain-based approach to tissue engi-
neer human heart valve leaflets has proven its feasibility
using the Diastolic Pulse Duplicator, offering new possibil-
ities towards tissue engineering of functional human aortic
heart valve replacements.
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